Benchmark Comp. (544052)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 50.84% and profit growth of 47.57% show strong recent momentum.
• Trailing P/E of 7.99 and PEG of 0.16 suggest undervaluation relative to growth.
• Piotroski F-Score of 7/9 indicates solid financial health on available metrics.
• Latest quarter shows a functioning profit-generating business: ₹29 Cr sales and ₹2 Cr net profit.

Concerns

• No disclosure of book value, ROE, debt/equity, or promoter holding limits thorough due diligence.
• ROCE of only 8.11% suggests modest returns on capital, not a high-quality franchise.
• Zero dividend means shareholders depend entirely on price appreciation for returns.
• Micro-cap with ₹42 Cr market cap and stock already up from ₹18 to ₹58.90 carries liquidity and mean-reversion risk.

AI Analysis

At ₹58.90, Benchmark Comp. is a micro-cap IT-enabled services company with a market capitalisation of only ₹42 crore. The headline numbers look intriguing: a trailing P/E of 7.99, sales growth of 50.84%, profit growth of 47.57%, and a PEG of 0.16. On the surface, that is the kind of growth-at-a-bargain-price that Graham would study. But I cannot rely on figures alone. There is no data on book value, ROE, debt-equity, or promoter holding. That bothers me. A company's balance sheet and its owner are the first things I want to understand. ROCE of 8.11% is not a sign of an exceptional franchise; it suggests modest use of capital. The Piotroski score of 7/9 is a positive signal, implying improving financial health, but it does not reveal the durability of the business. The latest quarter shows ₹29 crore sales and ₹2 crore net profit, a thin margin of around 7%. Zero dividend means any return must come entirely from price appreciation, which makes valuation even more important. The stock has already moved from ₹18 to ₹58.90 in 52 weeks. Lower-quality small caps often show explosions in earnings, and I have learned to be cautious when numbers look too good. If the growth continues, 7.99 times earnings is undemanding; if it slows, the market can punish the stock quickly. I would classify this as a fast grower, but it is not yet a buy for me. I want more information on the balance sheet, cash flows, promoters, and competitive position. Without that, I am investing on hope, not analysis.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer